A detailed history of Krs Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Krs Capital Management, LLC holds 330 shares of REGN stock, worth $249,747. This represents 0.25% of its overall portfolio holdings.

Number of Shares
330
Previous 330 -0.0%
Holding current value
$249,747
Previous $346,000 -0.0%
% of portfolio
0.25%
Previous 0.26%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$692.45 - $844.37 $10,386 - $12,665
-15 Reduced 4.35%
330 $271,000
Q1 2023

Apr 11, 2023

SELL
$680.49 - $826.97 $6,804 - $8,269
-10 Reduced 2.82%
345 $283,000
Q4 2022

Jan 19, 2023

BUY
$705.89 - $766.39 $28,235 - $30,655
40 Added 12.7%
355 $0
Q3 2022

Oct 21, 2022

BUY
$573.97 - $724.32 $180,800 - $228,160
315 New
315 $216,000
Q2 2022

Aug 02, 2022

SELL
$548.35 - $738.84 $172,730 - $232,734
-315 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$543.48 - $670.97 $171,196 - $211,355
315 New
315 $198,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Krs Capital Management, LLC Portfolio

Follow Krs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.